Alexion Pharmaceuticals - Company & Market Research Reports

Home /
Companies /
Alexion Pharmaceuticals

Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with devastating and rare diseases. Alexion developed Soliris for the treatment of patients with paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome. Soliris is approved in more than 50 countries for PNH and more than 40 countries for aHUS. Alexion's company headquarters are based Cheshire, Connecticut, United States.

REFINE BY

KEYWORD

CATEGORIES

Drug Discovery 49
Central Nervous System Drugs 38
Immune Disorders Drugs 24
Biopharmaceuticals 22
Endocrine and Metabolic Disorders Drugs 21
Biotechnology 19
Hematological Drugs 19
Oncology Drugs 13
Pharmaceuticals 13
Liver and Kidney Disorders Drugs 12
Allergy and Immunology 10
Genomics 10
Musculoskeletal Disorders Drugs 10
Cardiovascular Drugs 9
Drugs by Therapeutic Area 8
Enzymes 8
Optical Disorders Drugs 6
Infusions and Injectables 6
Company Reports 5
Drug Delivery 5
Hematology 5
Therapeutic Area 4
Clinical Trials 4
Diagnostics 4
Needles and Syringes 4
Infectious Diseases Drugs 3
Proteomics 3
Laboratory Equipment 3
Pharmaceutical Manufacturing 3
Pharmaceutical Intermediates 2
In Vitro Diagnostics 2
Optical 2
Vaccines 2
Respiratory Drugs 2
Biosimilars and Biosuperiors 2
Dermatological Drugs 2
Allergy Drugs 2
Addiction Disorders Drugs 1
Urology and Nephrology 1
Pharmacoeconomics 1
Leukemia Drugs 1
Lymphoma Drugs 1
Colon Cancer Drugs 1
Bioinformatics 1
Cardiovascular Devices 1
Stents 1
Infectious Disease Testing 1
Analgesics 1
Cough and Cold Drugs 1
Diabetes Devices 1
Transdermal and Transmucosal Drug Delivery 1
Blood Banking 1
Medical Devices 1
Biomarkers 1
Gastrointestinal Drugs 1
Nanomedicine 1
Gastroenterology 1
Oncology 1
Immunosuppressive Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



276 reviews

271 Results (Page 11 of 14)
- Relevance
  Sort by

Myasthenia Gravis Treatment Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2019-2029F

 Report
May 2024
185 Pages
Global

From

€4446EUR$4,500USD£3,701GBP

Atypical Hemolytic Uremic Syndrome Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
August 2024
83 Pages
Global

From

€3500EUR$3,795USD£3,015GBP

Paroxysmal Nocturnal Hemoglobinuria Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
August 2024
86 Pages
Global

From

€3500EUR$3,795USD£3,015GBP

Lysosomal Disease Treatment Global Market Report 2024

 Report
January 2024
200 Pages
Global

From

€4940EUR$5,000USD£4,112GBP

Orphan Drugs Market by Disease Type, Product Type, Distribution Channel - Global Forecast 2025-2030

 Report
October 2024
181 Pages
Global

From

€3503EUR$3,545USD£2,915GBP

€3892EUR$3,939USD£3,239GBP

NEED HELP FINDING THE RIGHT PRODUCT? Becky will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Tendonitis Treatment Market Size, Share & Industry Trends Analysis Report By Type (Therapy and Surgery), By Therapy Type (Physical Therapy, Hot & Cold Therapy and Shockwave Therapy), By Condition, By Regional Outlook and Forecast, 2022 - 2028

 Report
November 2022
221 Pages
Global

From

€3557EUR$3,600USD£2,961GBP

Multiple Sclerosis Drugs Global Market Report 2024

 Report
February 2024
250 Pages
Global

From

€4940EUR$5,000USD£4,112GBP

Rare Disease Genetic Testing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029

 Report
February 2024
120 Pages
Global

From

€4693EUR$4,750USD£3,906GBP

Germany Myasthenia Gravis Treatment Market By Drug class, By Age group, By Distribution channel: Opportunity Analysis and Industry Forecast, 2023-2032

 Report
May 2023
86 Pages
Germany

From

€2327EUR$2,355USD£1,937GBP

Myasthenia Gravis - Market Insight, Epidemiology And Market Forecast - 2034

 Report
August 2024
287 Pages
Global

From

€5499EUR$5,565USD£4,577GBP

€7855EUR$7,950USD£6,538GBP

Neuromyelitis Optica Spectrum Disorder (NMOSD) - Pipeline Insight, 2024

 Clinical Trials
April 2024
50 Pages
Global

From

€1037EUR$1,050USD£864GBP

€1482EUR$1,500USD£1,234GBP

Myasthenia Gravis - Pipeline Insight, 2024

 Clinical Trials
June 2024
80 Pages
Global

From

€1383EUR$1,400USD£1,151GBP

€1976EUR$2,000USD£1,645GBP

PNH and aHUS Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2023
74 Pages
Global

From

€3500EUR$3,795USD£3,015GBP

DNA Repair Drugs Global Market Report 2024

 Report
February 2024
175 Pages
Global

From

€4940EUR$5,000USD£4,112GBP

Lysosomal Acid Lipase Deficiency Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2024
86 Pages
Global

From

€3500EUR$3,795USD£3,015GBP

Transverse Myelitis - Pipeline Insight, 2024

 Clinical Trials
April 2024
60 Pages
Global

From

€1383EUR$1,400USD£1,151GBP

€1976EUR$2,000USD£1,645GBP

Ubiquitin Enzyme Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
July 2024
97 Pages
Global

From

€3500EUR$3,795USD£3,015GBP

Sandhoff Disease Market Report and Forecast 2024-2032

 Report
February 2024
180 Pages
Global

From

€5433EUR$5,499USD£4,522GBP

Orphan Drugs Market Analysis & Forecast 2024-2034: Market By Drug Type; By Therapy; By Distribution Channel; and By Region

 Report
October 2023
145 Pages
Global

From

€3112EUR$3,150USD£2,591GBP

AL Amyloidosis Treatment Market Report and Forecast 2023-2031

 Report
March 2023
147 Pages
Global

From

€5927EUR$5,999USD£4,934GBP

271 Results (Page 11 of 14)
- 1
- 9
- 10
- 11
- 12
- 13

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.